Yingxiao Cao
4PUBLICATIONS
2CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (4)
Sort by Publication Date:
|May 23, 2020
Lestaurtinib potentiates TRAIL-induced apoptosis in glioma via CHOP-dependent DR5 induction.Yingxiao Cao, Shiqi Kong, Yuling Xin
|Apr 12, 2020
CDK4/6 inhibition suppresses tumour growth and enhances the effect of temozolomide in glioma cells.Yingxiao Cao, Xin Li, Shiqi Kong
|Mar 18, 2020
MiR-3116 sensitizes glioma cells to temozolomide by targeting FGFR1 and regulating the FGFR1/PI3K/AKT pathway.Shiqi Kong, Yingxiao Cao, Xin Li
|Mar 10, 2020
miR-152-5p suppresses glioma progression and tumorigenesis and potentiates temozolomide sensitivity by targeting FBXL7.Shiqi Kong, Yanwei Fang, Bingqian Wang
Pageof 1
